![Stella Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stella Xu
Direktor/Vorstandsmitglied bei
HBM HEALTHCARE INVESTMENTS AG
Vermögen: 486 392 $ am 31.08.2026
Profil
Stella Xu is currently Managing Director at Quan Capital Management LLC since 2017.
Dr. Xu is Director at Walking Fish Therapeutics, Inc. since 2019.
Dr. Xu is Director at Zidan Medical, Inc. since 2018.
Dr. Xu is Director at Therorna, Inc. Former positions include Director at TempestTx, Inc., Director at ARMO Biosciences, Inc. from 2017 to 2018, Independent Director at NextCure, Inc. from 2018 to 2021, Director at Centrexion Therapeutics Corp.
from 2018 to 2022, Director at Tempest Therapeutics, Inc. from 2018 to 2022, Independent Director at Design Therapeutics, Inc. from 2020 to 2024, and Vice President, Site Head-R&D Center China at Roche Innovation Center from 2012 to 2017.
Education includes undergraduate degree from Peking University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 1’683 ( 0.03% ) | 486 392 $ | 31.08.2026 |
Aktive Positionen von Stella Xu
| Unternehmen | Position | Beginn |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Direktor/Vorstandsmitglied | 01.06.2020 |
Quan Capital Management LLC
 Quan Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 01.08.2017 |
Zidan Medical, Inc.
 Zidan Medical, Inc. Medical SpecialtiesHealth Technology Develops endobronchial radiofrequency ablation devices for treatment of lung cancer | Direktor/Vorstandsmitglied | 01.11.2018 |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Direktor/Vorstandsmitglied | 01.06.2019 |
Therorna, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stella Xu
| Unternehmen | Position | Ende |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.06.2024 |
| TEMPEST THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.01.2022 |
| CENTREXION THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | 01.01.2022 |
| NEXTCURE, INC. | Direktor/Vorstandsmitglied | 30.09.2021 |
| ░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Stella Xu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for chronic pain and autoimmune disease | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Quan Capital Management LLC
Quan Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Roche Innovation Center | |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
Zidan Medical, Inc.
Zidan Medical, Inc. Medical SpecialtiesHealth Technology Develops endobronchial radiofrequency ablation devices for treatment of lung cancer | Health Technology |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Therorna, Inc. |
